eli lilly glp 1 drug FDA approves Foundayo, an oral GLP-1 alternative to Wegovy and Ozempic Eli Lilly Weight-Loss Pill Shows

Background Glucagon-like peptide-1 (GLP-1) induces diuresis and natriuresis

This study aims to comprehensively review the impact of GLP-1 RAs on various body systems, emphasizing both positive and negative effects while addressing existing knowledge gaps in the literature

Preclinical studies have confirmed that GIPRGLP1R coagonists improve several hallmarks of metabolic syndrome, such as obesity, hyperglycemia, and dyslipidemia

Nevertheless, the overall drug exposure was not considered clinically significant

As the popularity of GLP-1 drugs continues to skyrocket, there has also been a huge rise in overdoses

Deal Snapshot: Novo is partnering with Ascendis on less frequently dosed drugs for metabolic diseases, committing up to $285m for a lead program, a once-monthly GLP-1 receptor agonist.